653 related articles for article (PubMed ID: 27490486)
21. Graphene oxide/manganese ferrite nanohybrids for magnetic resonance imaging, photothermal therapy and drug delivery.
Yang Y; Shi H; Wang Y; Shi B; Guo L; Wu D; Yang S; Wu H
J Biomater Appl; 2016 Jan; 30(6):810-22. PubMed ID: 26296777
[TBL] [Abstract][Full Text] [Related]
22. Combination drug delivery via multilamellar vesicles enables targeting of tumor cells and tumor vasculature.
Liu Y; Kim YJ; Siriwon N; Rohrs JA; Yu Z; Wanga P
Biotechnol Bioeng; 2018 Jun; 115(6):1403-1415. PubMed ID: 29457630
[TBL] [Abstract][Full Text] [Related]
23. Hollow mesoporous silica nanoparticles for tumor vasculature targeting and PET image-guided drug delivery.
Chakravarty R; Goel S; Hong H; Chen F; Valdovinos HF; Hernandez R; Barnhart TE; Cai W
Nanomedicine (Lond); 2015; 10(8):1233-46. PubMed ID: 25955122
[TBL] [Abstract][Full Text] [Related]
24. Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug.
Wang H; Gu W; Xiao N; Ye L; Xu Q
Int J Nanomedicine; 2014; 9():1433-42. PubMed ID: 24672236
[TBL] [Abstract][Full Text] [Related]
25. High efficient anti-cancer drug delivery systems using tea polyphenols reduced and functionalized graphene oxide.
Wang X; Hao L; Zhang C; Chen J; Zhang P
J Biomater Appl; 2017 Mar; 31(8):1108-1122. PubMed ID: 28084865
[TBL] [Abstract][Full Text] [Related]
26. Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer.
Moura V; Lacerda M; Figueiredo P; Corvo ML; Cruz ME; Soares R; de Lima MC; Simões S; Moreira JN
Breast Cancer Res Treat; 2012 May; 133(1):61-73. PubMed ID: 21805188
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and characterization of an octaarginine functionalized graphene oxide nano-carrier for gene delivery applications.
Imani R; Emami SH; Faghihi S
Phys Chem Chem Phys; 2015 Mar; 17(9):6328-39. PubMed ID: 25650242
[TBL] [Abstract][Full Text] [Related]
28. A specific peptide ligand-modified lipid nanoparticle carrier for the inhibition of tumor metastasis growth.
Wang Z; Yu Y; Dai W; Cui J; Wu H; Yuan L; Zhang H; Wang X; Wang J; Zhang X; Zhang Q
Biomaterials; 2013 Jan; 34(3):756-64. PubMed ID: 23117217
[TBL] [Abstract][Full Text] [Related]
29. Spatiotemporal assessment of spontaneous metastasis formation using multimodal in vivo imaging in HER2+ and triple negative metastatic breast cancer xenograft models in mice.
Fricke IB; De Souza R; Costa Ayub L; Francia G; Kerbel R; Jaffray DA; Zheng J
PLoS One; 2018; 13(5):e0196892. PubMed ID: 29723251
[TBL] [Abstract][Full Text] [Related]
30. Magnetic single-walled carbon nanotubes as efficient drug delivery nanocarriers in breast cancer murine model: noninvasive monitoring using diffusion-weighted magnetic resonance imaging as sensitive imaging biomarker.
Al Faraj A; Shaik AP; Shaik AS
Int J Nanomedicine; 2015; 10():157-68. PubMed ID: 25565811
[TBL] [Abstract][Full Text] [Related]
31. Dual-targeted hybrid nanoparticles of synergistic drugs for treating lung metastases of triple negative breast cancer in mice.
Zhang T; Prasad P; Cai P; He C; Shan D; Rauth AM; Wu XY
Acta Pharmacol Sin; 2017 Jun; 38(6):835-847. PubMed ID: 28216624
[TBL] [Abstract][Full Text] [Related]
32. Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.
Shi S; Yang K; Hong H; Valdovinos HF; Nayak TR; Zhang Y; Theuer CP; Barnhart TE; Liu Z; Cai W
Biomaterials; 2013 Apr; 34(12):3002-9. PubMed ID: 23374706
[TBL] [Abstract][Full Text] [Related]
33. Somatostatin Receptor-Mediated Tumor-Targeting Nanocarriers Based on Octreotide-PEG Conjugated Nanographene Oxide for Combined Chemo and Photothermal Therapy.
Zhang X; Yang C; Zhou J; Huo M
Small; 2016 Jul; 12(26):3578-90. PubMed ID: 27244649
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional Nanosystem Based on Graphene Oxide for Synergistic Multistage Tumor-Targeting and Combined Chemo-Photothermal Therapy.
Zhang H; Li Y; Pan Z; Chen Y; Fan Z; Tian H; Zhou S; Zhang Y; Shang J; Jiang B; Wang F; Luo F; Hou Z
Mol Pharm; 2019 May; 16(5):1982-1998. PubMed ID: 30892898
[TBL] [Abstract][Full Text] [Related]
35. Graphene oxide-based magnetic fluorescent hybrids for drug delivery and cellular imaging.
Gao Y; Zou X; Zhao JX; Li Y; Su X
Colloids Surf B Biointerfaces; 2013 Dec; 112():128-33. PubMed ID: 23973670
[TBL] [Abstract][Full Text] [Related]
36. The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin.
Xiong XB; Ma Z; Lai R; Lavasanifar A
Biomaterials; 2010 Feb; 31(4):757-68. PubMed ID: 19818492
[TBL] [Abstract][Full Text] [Related]
37. Neovasculature and circulating tumor cells dual-targeting nanoparticles for the treatment of the highly-invasive breast cancer.
Yao J; Feng J; Gao X; Wei D; Kang T; Zhu Q; Jiang T; Wei X; Chen J
Biomaterials; 2017 Jan; 113():1-17. PubMed ID: 27794222
[TBL] [Abstract][Full Text] [Related]
38. Highly efficient nuclear delivery of anti-cancer drugs using a bio-functionalized reduced graphene oxide.
Zheng XT; Ma XQ; Li CM
J Colloid Interface Sci; 2016 Apr; 467():35-42. PubMed ID: 26773607
[TBL] [Abstract][Full Text] [Related]
39. "Gold nanoparticles composite-folic acid conjugated graphene oxide nanohybrids" for targeted chemo-thermal cancer ablation: In vitro screening and in vivo studies.
Chauhan G; Chopra V; Tyagi A; Rath G; Sharma RK; Goyal AK
Eur J Pharm Sci; 2017 Jan; 96():351-361. PubMed ID: 27721039
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
